Skip to main content

Advertisement

SpringerLink
Log in

Metastatic Osteosarcoma Gene Expression Differs In Vitro and In Vivo

  • Symposium: Molecular Genetics in Sarcoma
  • Published:
Clinical Orthopaedics and Related Research

Abstract

An understanding of differential gene expression in highly metastatic osteosarcoma could provide gene targets for treatment of metastases. We compared gene expression profiles of high- (LM7) and low- (LM2) metastatic SaOS2-derived cell lines in an in vitro tissue culture model and examined several differentially regulated genes in vivo in a murine orthotopic xenograft model. We hypothesized an orthotopic inoculation of LM2 and LM7 cells would establish a primary lesion and the gene expression profile of cells grafted in this fashion would resemble the gene expression profile observed in an in vitro model. Thirty-five days after inoculation, animals were euthanized and both tibiae were harvested and rapidly frozen in liquid nitrogen. Human-specific GAPDH mRNA was present in two of four tibias inoculated with LM2 cells and three of four tibias inoculated with LM7 cells. Tibiae displaying the presence of human cells were assayed by semiquantitative reverse transcriptase polymerase chain reaction. We observed poor correspondence of in vitro to in vivo gene expression for either cell line. Accordingly, in vitro osteosarcoma gene expression data must be interpreted with caution until confirmed in vivo. Our orthotopic injection model allowed in vivo study of differential gene expression between these two cell lines but did not show radiographic evidence of an established primary lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Arrington SA, Schoonmaker JE, Damron TA, Mann KA, Allen MJ. Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis. Bone. 2006;38:359–367.

    Article  PubMed  CAS  Google Scholar 

  2. Azuma K, Tanaka M, Uekita T, Inoue S, Yokota J, Ouchi Y, Sakai R. Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma. Oncogene. 2005;24:4754–4764.

    Article  PubMed  CAS  Google Scholar 

  3. Berlin O, Samid D, Donthineni-Rao R, Akeson W, Amiel D, Woods VL Jr. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res. 1993;53:4890–4895.

    PubMed  CAS  Google Scholar 

  4. Cantiani L, Manara MC, Zucchini C, De Sanctis P, Zuntini M, Valvassori L, Serra M, Olivero M, Di Renzo MF, Colombo MP, Picci P, Scotlandi K. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cancer Res. 2007;67:7675–7685.

    Article  PubMed  CAS  Google Scholar 

  5. Crnalic S, Hakansson I, Boquist L, Lofvenberg R, Brostrom LA. A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice. Clin Exp Metastasis. 1997;15:164–172.

    Article  PubMed  CAS  Google Scholar 

  6. Curto M, McClatchey AI. Ezrin...a metastatic detERMinant? Cancer Cell. 2004;5:113–114.

    Article  PubMed  CAS  Google Scholar 

  7. Dalla-Torre CA, Yoshimoto M, Lee CH, Joshua AM, de Toledo SR, Petrilli AS, Andrade JA, Chilton-MacNeill S, Zielenska M, Squire JA. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma. BMC Cancer. 2006;6:237.

    Article  PubMed  Google Scholar 

  8. Dass CR, Contreras KG, Dunstan DE, Choong PF. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials. 2007;28:3026–3033.

    Article  PubMed  CAS  Google Scholar 

  9. Dass CR, Ek ET, Contreras KG, Choong PF. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis. 2006;23:367–380.

    Article  PubMed  Google Scholar 

  10. Duan X, Jia SF, Zhou Z, Langley RR, Bolontrade MF, Kleinerman ES. Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells. Clin Exp Metastasis. 2004;21:747–753.

    Article  PubMed  CAS  Google Scholar 

  11. Dunn TB, Andervont HB. Histology of some neoplasms and non-neoplastic lesions found in wild mice maintained under laboratory conditions. J Natl Cancer Inst. 1963;31:873–901.

    PubMed  CAS  Google Scholar 

  12. Ek ET, Dass CR, Choong PF. Commonly used mouse models of osteosarcoma. Crit Rev Oncol Hematol. 2006;60:1–8.

    Article  PubMed  Google Scholar 

  13. Ek ET, Dass CR, Contreras KG, Choong PF. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther. 2007;14:616–626.

    Article  PubMed  CAS  Google Scholar 

  14. Fisher JL, Mackie PS, Howard ML, Zhou H, Choong PF. The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model. Clin Cancer Res. 2001;7:1654–1660.

    PubMed  CAS  Google Scholar 

  15. Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumors cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977;59:221–226.

    PubMed  CAS  Google Scholar 

  16. Fukuda T, Kido A, Kajino K, Tsutsumi M, Miyauchi Y, Tsujiuchi T, Konishi Y, Hino O. Cloning of differentially expressed genes in highly and low metastatic rat osteosarcomas by a modified cDNA-AFLP method. Biochem Biophys Res Commun. 1999;261:35–40.

    Article  PubMed  CAS  Google Scholar 

  17. Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R, Holcombe RF, Hoang BH. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res. 2007;25:964–971.

    Article  PubMed  CAS  Google Scholar 

  18. Haupt LM, Thompson EW, Trezise AE, Irving RE, Irving MG, Griffiths LR. In vitro and in vivo MMP gene expression localisation by in situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts. BMC Cancer. 2006;6:18.

    Article  PubMed  Google Scholar 

  19. Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R, Huvos AG, Meyers PA, Gorlick R. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer. 2004;109:106–111.

    Article  PubMed  CAS  Google Scholar 

  20. Hu D, Man Z, Wang P, Tan X, Wang X, Takaku S, Hyuga S, Sato T, Yao X, Yamagata S, Yamagata T. Ganglioside GD1a negatively regulates matrix metalloproteinase-9 expression in mouse FBJ cell lines at the transcriptional level. Connect Tissue Res. 2007;48:198–205.

    Article  PubMed  CAS  Google Scholar 

  21. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med. 2004;10:201–204.

    Article  PubMed  CAS  Google Scholar 

  22. Husmann K, Muff R, Bolander ME, Sarkar G, Born W, Fuchs B. Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis. Mol Carcinog. 2008;47:66–73.

    Article  PubMed  CAS  Google Scholar 

  23. Jia SF, Worth LL, Kleinerman ES. A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis. 1999;17:501–506.

    Article  PubMed  CAS  Google Scholar 

  24. Kashima T, Nakamura K, Kawaguchi J, Takanashi M, Ishida T, Aburatani H, Kudo A, Fukayama M, Grigoriadis AE. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer. 2003;104:147–154.

    Article  PubMed  CAS  Google Scholar 

  25. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 2001;61:3750–3759.

    PubMed  CAS  Google Scholar 

  26. Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis. 2000;18:261–271.

    Article  PubMed  CAS  Google Scholar 

  27. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10:182–186.

    Article  PubMed  CAS  Google Scholar 

  28. Lafleur EA, Koshkina NV, Stewart J, Jia SF, Worth LL, Duan X, Kleinerman ES. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Clin Cancer Res. 2004;10:8114–8119.

    Article  PubMed  CAS  Google Scholar 

  29. Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res. 2005;11:2561–2567.

    Article  PubMed  CAS  Google Scholar 

  30. Lund S, Christensen KV, Hedtjarn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, Porzgen P, Leist M. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol. 2006;180:71–87.

    Article  PubMed  CAS  Google Scholar 

  31. Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, Haydon RC, Rinker-Schaeffer CW, He TC. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis. 2005;22:319–329.

    Article  PubMed  Google Scholar 

  32. Luu HH, Zhou L, Haydon RC, Deyrup AT, Montag AG, Huo D, Heck R, Heizmann CW, Peabody TD, Simon MA, He TC. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 2005;229:135–148.

    Article  PubMed  CAS  Google Scholar 

  33. Ma S, Guan XY, Beh PS, Wong KY, Chan YP, Yuen HF, Vielkind J, Chan KW. The significance of LMO2 expression in the progression of prostate cancer. J Pathol. 2007;211:278–285.

    Article  PubMed  CAS  Google Scholar 

  34. MacEwen EG, Pastor J, Kutzke J, Tsan R, Kurzman ID, Thamm DH, Wilson M, Radinsky R. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. J Cell Biochem. 2004;92:77–91.

    Article  PubMed  CAS  Google Scholar 

  35. Nakano T, Tani M, Ishibashi Y, Kimura K, Park YB, Imaizumi N, Tsuda H, Aoyagi K, Sasaki H, Ohwada S, Yokota J. Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis. 2003;20:665–674.

    Article  PubMed  CAS  Google Scholar 

  36. Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Hum Pathol. 2000;31:709–716.

    Article  PubMed  CAS  Google Scholar 

  37. Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Yokoyama R, Iwamoto Y, Tsuneyoshi M. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol. 2006;19:738–745.

    Article  PubMed  CAS  Google Scholar 

  38. Ogino W, Takeshima Y, Mori T, Yanai T, Hayakawa A, Akisue T, Kurosaka M, Matsuo M. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis. J Pediatr Hematol Oncol. 2007;29:435–439.

    Article  PubMed  CAS  Google Scholar 

  39. Srivastava A, Fuchs B, Zhang K, Ruan M, Halder C, Mahlum E, Weber K, Bolander ME, Sarkar G. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis. Clin Cancer Res. 2006;12:4237–4243.

    Article  PubMed  CAS  Google Scholar 

  40. Suryo Rahmanto Y, Dunn LL, Richardson DR. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo. Carcinogenesis. 2007;28:2172–2183.

    Article  PubMed  CAS  Google Scholar 

  41. Tatenhorst L, Puttmann S, Senner V, Paulus W. Genes associated with fast glioma cell migration in vitro and in vivo. Brain Pathol. 2005;15:46–54.

    PubMed  CAS  Google Scholar 

  42. Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, Coleman CN, Mitchell JB, Chuang EY. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res. 2007;67:3845–3852.

    Article  PubMed  CAS  Google Scholar 

  43. Yan T, Wunder JS, Gokgoz N, Gill M, Eskandarian S, Parkes RK, Bull SB, Bell RS, Andrulis IL. COPS3 amplification and clinical outcome in osteosarcoma. Cancer. 2007;109:1870–1876.

    Article  PubMed  CAS  Google Scholar 

  44. Yanagawa T, Watanabe H, Takeuchi T, Fujimoto S, Kurihara H, Takagishi K. Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta. Lab Invest. 2004;84:513–522.

    Article  PubMed  CAS  Google Scholar 

  45. Yang R, Hoang BH, Kubo T, Kawano H, Chou A, Sowers R, Huvos AG, Meyers PA, Healey JH, Gorlick R. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma. Int J Cancer. 2007;121:943–954.

    Article  PubMed  CAS  Google Scholar 

  46. Zucchini C, Bianchini M, Valvassori L, Perdichizzi S, Benini S, Manara MC, Solmi R, Strippoli P, Picci P, Carinci P, Scotlandi K. Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene. Bone. 2004;34:672–679.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Frank Middleton, PhD, Meredith Pritchard, and Mingliang Zhang, MD, PhD, for their assistance in manuscript preparation. We are particularly indebted to Yan Wang, MD, who did much of the early work on this project when she was a postdoctoral research fellow in our laboratory.

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Musculoskeletal Sciences Research Center, SUNY Upstate Medical University, Suite 130, 550 Harrison Street, Syracuse, NY, 13202, USA

    Jennifer W. Lisle MD, Joseph Y. Choi MD, PhD, Jason A. Horton BS, Matthew J. Allen VetMB, PhD & Timothy A. Damron MD

Authors
  1. Jennifer W. Lisle MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Y. Choi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason A. Horton BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthew J. Allen VetMB, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Timothy A. Damron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy A. Damron MD.

Additional information

One or more of the authors (TAD) have received funding from grants from the Children’s Miracle Network and the David G. Murray Endowed Professorship.

Each author certifies that his or her institution has approved the animal protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.

About this article

Cite this article

Lisle, J.W., Choi, J.Y., Horton, J.A. et al. Metastatic Osteosarcoma Gene Expression Differs In Vitro and In Vivo. Clin Orthop Relat Res 466, 2071–2080 (2008). https://doi.org/10.1007/s11999-008-0309-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-008-0309-1

Keywords

Search

Navigation